The "moderately loose" monetary policy boosted the confidence of all parties. A50ETF Huabao (159596) attracted 17.02 million yuan of gold yesterday. On December 11, the Shanghai Composite Index fluctuated within a narrow range in the morning, and A50ETF Huabao (159596) fell slightly by 0.18% with a turnover of 84.21 million yuan. In terms of constituent stocks, the top ten awkward stocks are mixed. On the upside, Midea Group led the gains, followed by Zijin Mining and Changjiang Power. On the downside, Hengrui Pharma led the decline. In terms of capital flow, A50ETF Huabao (159596) received a net inflow of 17.02 million yuan yesterday. China Post Securities said that the the Political Bureau of the Communist Party of China (CPC) Central Committee meeting continued to actively set the tone, and the policy turned loose, and expanding domestic demand in all directions became the current policy direction. This meeting made it clear that "strengthening unconventional countercyclical adjustment" and the fiscal policy adjustment was "more active", which basically met market expectations; The monetary policy is set to be "moderately loose", and the tone is adjusted again after 14 years. Next year, it is expected to be wide in currency and credit.There is a wave of "restriction on purchases" in the public offering market. The announcement of Huitianfu Fund on December 11th shows that since December 12th, Huitianfu Enhanced Income Bond A has suspended large-scale subscription, large-scale conversion and large-scale fixed investment business, and the amount of single or multiple cumulative subscriptions, conversion and fixed investment in a single fund account per day should not exceed 10 million yuan (inclusive). Recently, the reporter found that there is a "restricted purchase tide" in the public offering market. Whether it is active equity funds, bond funds or QDII funds, many outstanding products have recently announced the suspension of large-scale subscription, and even QDII products have directly "closed the market" and suspended all buying operations. (CSI)Indian Rupee fell below 84.8575 against the US dollar, hitting an all-time low.
Starbucks China responded to the newly created position of Chief Growth Officer: to promote the sustainable development of Starbucks brand in China. Recently, some media reported that the management of Starbucks China continued to adjust and hired CGO to manage the growth from digital marketing companies. In response to the above information, Sina Technology verified Starbucks, and the official response said: China is Starbucks' largest international market and an important engine for the company's future growth. In November, Starbucks China established the Chief Growth Officer (CGO) organization and appointed Tony Yang as the company's Chief Growth Officer (CGO). The establishment of CGO organization will continue to strengthen Starbucks' coffee leadership, accelerate the product innovation with coffee as the core, better refresh customers' Starbucks experience at various contacts through integrated marketing strategies, and promote the sustainable development of Starbucks brand in China. At present, Starbucks has more than 7,600 stores in China, reaching a new development milestone covering 1,000 county-level markets. (Sina Technology)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.China Overseas Development: The annual interest of "23 Zhonghai 04" will be paid on December 12th. On December 10th, China Overseas Development (00688.HK) announced that China Overseas Enterprise Development Group Co., Ltd., a wholly-owned subsidiary of the company, will pay the annual interest of "23 Zhonghai 04" on December 12th, totaling 96 million yuan. The total amount of bonds issued in this issue is 3 billion yuan, and the issuance period is 5 years. The coupon rate of bonds in this issue is 3.20%.
Does the United States or cancel the recognition of the "Sham Liberation Organization" terrorist organization? US officials responded that according to media reports such as CNN, John Kirby, strategic communication coordinator of the US White House National Security Council, said on the 10th local time that the United States has not seriously discussed the cancellation of the Syrian opposition "Sharm Liberation Organization" (HTS) terrorist organization identification. Earlier, some media quoted an anonymous senior official of the US government as saying that the US government did not rule out removing HTS from the list of terrorist organizations recognized by the United States in order to establish closer ties with it. (World Wide Web)Vietnam Customs: The export volume of rice in November was 704,608 tons.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13